96524-70-8

Basic information

• Product Name: Methyl(p-formylphenyl)acetate
• Synonyms: Methyl(p-formylphenyl)acetate;(4-Formylphenyl)acetic acid methyl ester;4-Formylbenzeneacetic acid methyl ester;Methyl (4-formylphenyl)acetate;Methyl 2-(4-formylphenyl)acetate;Methyl 2-(4-formylphenyl);Benzeneacetic acid, 4-formyl-, methyl ester
• CAS NO: 96524-70-8
• Molecular Formula: C₁₀H₁₀O₃
• Molecular Weight: 178.1846
• Mol File: 96524-70-8.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 285℃
• Flash Point: 124℃
• Appearance: /
• Density: 1.157
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Methyl(p-formylphenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl(p-formylphenyl)acetate(96524-70-8)
• EPA Substance Registry System: Methyl(p-formylphenyl)acetate(96524-70-8)

Safety Data

• Hazardous Substances Data: 96524-70-8(Hazardous Substances Data)

Usage

General Description

Methyl(p-formylphenyl)acetate is a chemical compound with the molecular formula C11H12O3. It is an ester, which is a common type of organic compound, typically formed by reacting a carboxylic acid and an alcohol. Methyl(p-formylphenyl)acetate is used as a flavoring agent and fragrance in various consumer products, such as perfumes, soaps, and cosmetics. It has a sweet, fruity odor and is often used to impart a fruity or floral scent to products. Methyl(p-formylphenyl)acetate is also commonly used in the production of food flavorings and is regarded as safe for consumption in small quantities. Overall, methyl(p-formylphenyl)acetate plays a key role in the creation of pleasant smells and tastes in a wide range of everyday products.

Upstream product

• 73401-74-8 4-hydroxymethylphenylacetic acid 
• 75-36-5 acetyl chloride 
• 101-41-7 benzeneacetic acid methyl ester 
• 7398-42-7 methyl 2-(4-(bromomethyl)phenyl)acetate 
• 13737-36-5 4-bromophenylacetic acid 
• 147283-85-0 (4-Trifluoromethanesulfonyloxy-phenyl)-acetic acid methyl ester 
• 14199-15-6 Methyl 4-hydroxyphenylacetate 
• 156-38-7 4-hydroxyphenylacetate 
• 52798-01-3 methyl 4-cyanobenzeneacetate 
• 17833-56-6 ester monomethylique de l'acide p-phenylene diacetique 
• 155380-11-3 methyl 4-(hydroxymethyl)phenylacetate 
• 72770-09-3 4-(chloromethyl)-phenylacetic methylester 

Downstream Products

• 1613414-62-2 methyl 2-(4-(1,3-dioxolan-2-yl)phenyl)acetate 
• 7398-47-2 methyl 2-(4-(1-hydroxyethyl)phenyl)acetate 
• 87077-46-1 1-(4-ethyl-phenyl)-2-methyl-propan-2-ol 
• 1080008-41-8 methyl 2-(4-((N-(3-(4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl)propyl)-3-(piperidin-1-yl)propanamido)methyl)phenyl)acetate 
• 1080008-44-1 methyl 2-(4-(((3-(4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl)propyl)(3-morpholinopropyl)amino)methyl)phenyl)acetate 
• 1080008-18-9 methyl 2-(4-((N-(3-(4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl)propyl)-2-(piperidin-1-yl)acetamido)methyl)phenyl)acetate 
• 950502-41-7 [2-(2,6-dichloro-phenyl)-ethyl]-(4-{[2R-hydroxy-2-(4-hydroxy-2-oxo-2,3-dihydro-benzothiazol-7-yl)-ethylcarbamoyl]-methyl}-benzyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

Chemoselective Deoxygenation of 2° Benzylic Alcohols through a Sequence of Formylation and B(C6F5)3-Catalyzed Reduction

A sequence of formylation and B(C6F5)3-catalyzed reduction of the resulting formate with Et3SiH enables the chemoselective deoxygenation of secondary benzylic alcohols. Primary benzylic and tertiary non-benzylic alcohols are not reduced by this protocol. The formyl group fulfills a double role as activator and self-sacrificing protecting group. The deoxygenation of these formates is fast and can be carried out in the presence of other potentially reducible groups. Neighboring-group participation was found in the deoxygenation of certain diol motifs.

OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

The invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY

The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.